ID: ALA3342216
Max Phase: Preclinical
Molecular Formula: C25H30O11
Molecular Weight: 506.50
Molecule Type: Small molecule
Associated Items:
ID: ALA3342216
Max Phase: Preclinical
Molecular Formula: C25H30O11
Molecular Weight: 506.50
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(C)=CC(=O)O[C@H]1C(=O)O[C@@H]2C[C@H]3C(C)=C(O)C(=O)C[C@]3(C)[C@H]3[C@@H](O)[C@H](O)[C@]4(C(=O)O)OC[C@]32[C@@H]14
Standard InChI: InChI=1S/C25H30O11/c1-9(2)5-14(27)36-17-19-24-8-34-25(19,22(32)33)20(30)16(29)18(24)23(4)7-12(26)15(28)10(3)11(23)6-13(24)35-21(17)31/h5,11,13,16-20,28-30H,6-8H2,1-4H3,(H,32,33)/t11-,13+,16+,17+,18+,19+,20-,23-,24+,25+/m0/s1
Standard InChI Key: RIYGDELXURVOBZ-HVCNMUSHSA-N
Natural Product: Yes | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 506.50 | Molecular Weight (Monoisotopic): 506.1788 | AlogP: 0.43 | #Rotatable Bonds: 3 |
Polar Surface Area: 176.89 | Molecular Species: ACID | HBA: 10 | HBD: 4 |
#RO5 Violations: 1 | HBA (Lipinski): 11 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 3.46 | CX Basic pKa: | CX LogP: 0.09 | CX LogD: -3.31 |
Aromatic Rings: 0 | Heavy Atoms: 36 | QED Weighted: 0.31 | Np Likeness Score: 3.67 |
1. Tang W, Xie J, Xu S, Lv H, Lin M, Yuan S, Bai J, Hou Q, Yu S.. (2014) Novel nitric oxide-releasing derivatives of brusatol as anti-inflammatory agents: design, synthesis, biological evaluation, and nitric oxide release studies., 57 (18): [PMID:25179783] [10.1021/jm5007534] |
Source(1):